Differentially Expressed Genes and Molecular Pathways in an Autochthonous Mouse Prostate Cancer Model

Verma, Shiv and Shukla, Sanjeev and Pandey, Mitali and MacLennan, Gregory T. and Gupta, Sanjay (2019) Differentially Expressed Genes and Molecular Pathways in an Autochthonous Mouse Prostate Cancer Model. Frontiers in Genetics, 10. ISSN 1664-8021

[thumbnail of pubmed-zip/versions/2/package-entries/fgene-10-00235-r1/fgene-10-00235.pdf] Text
pubmed-zip/versions/2/package-entries/fgene-10-00235-r1/fgene-10-00235.pdf - Published Version

Download (6MB)

Abstract

Prostate cancer remains a major public health problem and the second leading cause of cancer-related deaths in men in the United States. The present study aims to understand the molecular pathway(s) of prostate cancer which is essential for early detection and treatment. Dorsolateral prostate from 20 week transgenic adenocarcinoma of the mouse prostate (TRAMP) mice, which spontaneously develops prostate cancer and recapitulates human disease and age-matched non-transgenic littermates were utilized for microarray analysis. Mouse genome network and pathway analyses were mapped to the human genome using the Ingenuity Pathway Analysis (IPA) database for annotation, visualization, and integrated discovery. In total, 136 differentially expressed genes, including 32 downregulated genes and 104 upregulated genes were identified in the dorsolateral prostate of TRAMP, compared to non-transgenic mice. A subset of differentially expressed genes were validated by qRT-PCR. Alignment with human genome database identified 18 different classes of proteins, among these, 36% were connected to the nucleic acid binding, including ribosomal proteins, which play important role in protein synthesis—the most enriched pathway in the development of prostate cancer. Furthermore, the results suggest deregulation of signaling molecules (9%) and enzyme modulators (8%) affect various pathways. An imbalance in other protein classes, including transporter proteins (7%), hydrolases (6%), oxidoreductases, and cytoskeleton proteins (5%), contribute to cancer progression. Our study evaluated the underlying pathways and its connection to human prostate cancer, which may further help assess the risk of disease development and progression and identify potential targets for therapeutic intervention.

Item Type: Article
Subjects: Academic Digital Library > Medical Science
Depositing User: Unnamed user with email info@academicdigitallibrary.org
Date Deposited: 16 Feb 2023 09:03
Last Modified: 18 May 2024 07:15
URI: http://publications.article4sub.com/id/eprint/623

Actions (login required)

View Item
View Item